These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6783148)

  • 21. Transient deficiency of antihemophilic factor (AHF) procoagulant and AHF-like antigen during administration of tetracycline.
    Stefanini M
    Am J Clin Pathol; 1980 Mar; 73(3):439-43. PubMed ID: 7361727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of VIII AHF response to adrenalin in hemophilia A.
    Eyster ME; Dranchak M; Haverstick J; Rogers JS
    Am J Hematol; 1977; 3():193-8. PubMed ID: 602937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of hemophilia carriers during pregnancy.
    Hoyer LW; Carta CA; Mahoney MJ
    Blood; 1982 Dec; 60(6):1407-10. PubMed ID: 6814553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combined use of monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for factor VIII antigen (VIII:Ag) and von Willebrand factor antigen (vWF:Ag) for the detection of carriers of haemophilia A.
    Furlong RA; Chesham J; Peake IR
    Clin Lab Haematol; 1988; 10(3):295-305. PubMed ID: 3141105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia.
    Bennett B; Ratnoff OD; Levin J
    J Clin Invest; 1972 Oct; 51(10):2597-601. PubMed ID: 4115706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of hemophilia A carriers by use of frozen plasma samples.
    Yang HC; Hardin J; Vaudreuil C
    Clin Chem; 1978 Sep; 24(9):1628-30. PubMed ID: 688629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype.
    Graham JB; Rizza CR; Chediak J; Mannucci PM; Briët E; Ljung R; Kasper CK; Essien EM; Green PP
    Blood; 1986 Jun; 67(6):1554-9. PubMed ID: 3085743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of carrier detection in haemophilia A by linear discriminant function.
    Shen MC
    Br J Haematol; 1982 Oct; 52(2):283-93. PubMed ID: 6812614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency).
    Giles AR; Tinlin S; Hoogendoorn H; Greenwood P; Greenwood R
    Blood; 1984 Feb; 63(2):451-6. PubMed ID: 6419797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved hemophilia A carrier detection by DDAVP stimulation of factor VIII.
    Kobrinsky NL; Watson CM; Cheang MS; Bishop AJ
    J Pediatr; 1984 May; 104(5):718-24. PubMed ID: 6425482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding symptoms in carriers of hemophilia A and B.
    Mauser Bunschoten EP; van Houwelingen JC; Sjamsoedin Visser EJ; van Dijken PJ; Kok AJ; Sixma JJ
    Thromb Haemost; 1988 Jun; 59(3):349-52. PubMed ID: 2847347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical correlates among 49 families with hemophilia A and factor VIII gene inversions.
    Weinmann AF; Schoof JM; Thompson AR
    Am J Hematol; 1996 Mar; 51(3):192-9. PubMed ID: 8619399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrence of von Willebrand's disease and hemophilia A: implications for carrier detection and prevalence.
    Miller CH; Hilgartner MW; Harris MB; Bussel JB; Aledort LM
    Am J Med Genet; 1986 May; 24(1):83-94. PubMed ID: 3085499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal diagnosis of classic hemophilia (hemophilia A) by immunoradiometric assays.
    Hoyer LW; Carta CA; Golbus MS; Hobbins JC; Mahoney MJ
    Blood; 1985 Jun; 65(6):1312-7. PubMed ID: 3922454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of Hemophilia A carrier state].
    Michalski R; Pniejnia-Olszyński W; Bykowska K; Lopaciuk S
    Acta Haematol Pol; 1977; 8(3):229-33. PubMed ID: 920063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-evaluation of plasmas from patients previously diagnosed as having von Willebrand's disease with the factor VIII-related antigen and ristocetin cofactor assay.
    Ness PM; Hymas PG; Perkins HA
    Am J Clin Pathol; 1979 Jan; 71(1):26-30. PubMed ID: 311154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower factor VIII coagulant in daughters of subjects with hemophilia A compared to other obligate carriers.
    Chediak J; Telfer MC; Jaojaroenkul T; Green D
    Blood; 1980 Apr; 55(4):552-8. PubMed ID: 7357083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.